About Spandan Khandelwal
Spandan's is a financial journalist and investment analyst focused on the stock market. With her ability to interpret financial data, she aims to help investors evaluate the fundamentals of a company before investing.
Spandan majored in accounting and finance in college and is currently pursuing the Cost and Management Accountant (CMA) program.
Recent Articles By Spandan Khandelwal
3 High-Volume Stocks to Add to Your Watchlist This Week
While experts expect the market to witness some relief rallies as most of the negatives have already been priced in, the persistent macroeconomic headwinds are expected to keep the volatility alive. Therefore, high-volume stocks Vale S.A. (VALE), Ambev (ABEV), and Nokia (NOK) could be great additions to your watchlist. Read on to learn more…
Electrify Your Portfolio With This 1 Energy Stock
Shares of electricity and natural gas supplier Genie Energy (GNE) have gained 64.9% over the past year. Given the company’s solid fundamentals, we think it could be wise to buy the stock now. Read on to learn more...
Ready to Retire? These 3 Stocks Could Help You Do It Earlier
Investors planning their retirement finances could benefit from investing in equities with stable return potential and consistent dividend payouts amid the current market volatility. On that front, investing in quality dividend-paying stocks Philip Morris (PM), Flowers Foods (FLO), and AbbVie (ABBV) could be rewarding. Read on…
Don't Sleep on This 1 Upgraded Stock
Movado Group (MOV) reported revenue growth across its segments in the last quarter and anticipated its earnings to soar over the coming quarters. Also, the stock has been recently upgraded to Strong Buy in our proprietary rating system. Read on to know why we think it’s an excellent addition to one’s portfolio now…
3 Stocks to Buy Hand-Over-Fist This Summer
The stock market has been under immense pressure on rising concerns over multi-decade high inflation, the Fed’s aggressive interest rate hikes, and increasing odds of a recession. Amid the current market downturn, it could be wise to invest in fundamentally sound stocks Enterprise Products (EPD), Broadcom (AVGO), and Yelp (YELP). Continue reading…
Is Novavax a Buy, Sell, or Hold Following FDA Decision?
Despite the FDA authorization of Novavax’s (NVAX) two-dose vaccine, the possible side effects and slow vaccine uptake keep the stock under pressure. So, let’s evaluate if it is worth adding the stock to one’s portfolio now. Read on…
2 Medical Stocks That Are Attractive Buys Right Now
Amid an inflationary environment, the medical sector is poised to stay afloat given the inelastic demand for medical products and services, impressive breakthroughs, and the rising need to serve an aging population. Therefore, fundamentally sound medical stocks Abbott Laboratories (ABT) and Utah Medical Products (UTMD) could be solid investments right now. Read on to learn more…
Want to Diversify Your Portfolio? These 3 Top ETFs Could Help
Despite a relief rally on Friday, the multi-decade high inflation, prospects of higher interest rates, and increasing odds of a recession are expected to keep the stock market under pressure. So, investing in WisdomTree Floating Rate (USFR), JPMorgan Ultra-Short Municipal (JMST), and ProShares Short (SH) could help diversify one’s portfolio and mitigate the market fluctuations significantly. Read on…
FUBO Is Down More Than 80% This Year. Should Long-Term Investors Buy the Stock Now?
fuboTV (FUBO) reported disappointing first-quarter results. Moreover, analysts lowered their expectations for this stock owing to slow streaming ad-revenue growth. However, since the stock has declined more than 80% year-to-date, would it be worth adding the stock to your portfolio for long-term returns? Let’s find out...